3d tumor1920
Application Note

3D tumor spheroid analysis method for HTS drug discovery using Celigo imaging cytometer

Inhibition of cancer cell proliferation in drug discovery research has not translated well from traditional two dimensional (2D) in vitro assays to in vivo studies. Most anti-cancer drug compound studies are performed in a tissue culture treated, 2D-assay format for the purpose of studying proliferation, viability, and apoptosis. Increasingly, scientific evidence is showing that growing cancer cells in the form of three-dimensional (3D) spheroids is more predictive of in vivo study outcomes than 2D cell culture formats.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

3D tumor spheroid analysis method for HTS drug discovery using Celigo imaging cytometer

Download Application Note